Methylomics of Breast Cancer: Seeking Epimarkers in Peripheral Blood of Young Subjects Publisher Pubmed



Khakpour G¹ ; Noruzinia M² ; Izadi P¹ ; Karami F³ ; Ahmadvand M⁴ ; Heshmat R⁵ ; Amoli MM⁶ ; Tavakkolybazzaz J¹
Source: Tumor Biology Published:2017

Abstract

Critical roles of epigenomic alterations in the pathogenesis of breast cancer have recently seized great attentions toward finding epimarkers in either non-invasive or semi-non-invasive samples as well as peripheral blood. In this way, methylated DNA immunoprecipitation microarray (MeDIP-chip) was performed on DNA samples isolated from white blood cells of 30 breast cancer patients compared to 30 healthy controls. A total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction. Hypermethylation of APC, HDAC1, and GSK1 genes has been previously reported in more than one study on tissue samples of breast cancer. Methylation of those aforementioned genes in white blood cells of our young patients not only relies on their importance in breast cancer pathogenesis but also may highlight their potential as early epimarkers that makes further assessments necessary in large cohort studies. © 2017, © The Author(s) 2017.